Hubing Shi

Years Active: 2019-2024
Publications (10 Years): 5

Sichuan University

Tsinghua University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sichuan University

China

Professor :: West China Hospital

Education History

Tsinghua University

China

PHD

Publications

Xiaowei Liu, Fengli Zuo, Jinen Song, Leyi Tang, Xueyan Wang, Xinyu Liu, Hao Zhang, Zhankun Yang, Jing Jing, Xuelei Ma, Hubing Shi
Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance. Cell discovery 10 (1) (2024)
Xiaowei Liu, Fengli Zuo, Jinen Song, Leyi Tang, Xueyan Wang, Xinyu Liu, Hao Zhang, Zhankun Yang, Jing Jing, Xuelei Ma, Hubing Shi
Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance. Cell discovery 10 (1) (2024)
Chune Yu, Dan Luo, Jing Yu, Min Zhang, Xiaobo Zheng, Guangchao Xu, Jiaxin Wang, Huiling Wang, Yufei Xu, Ke Jiang, Jie Xu, Xue-Lei Ma, Jing Jing, Hubing Shi
Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer. Oncogene (2021)
Chune Yu, Min Zhang, Jinen Song, Xiaobo Zheng, Guangchao Xu, Yu Bao, Jiang Lan, Dan Luo, Jianping Hu, Jingyi Jessica Li, Hubing Shi
Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapy. Molecular biomedicine 1 (1) (2020)
Wei Vivian Li, Shan Li, Xin Tong, Ling Deng, Hubing Shi, Jingyi Jessica Li
AIDE: annotation-assisted isoform discovery with high precision. Genome research 29 (12) (2019)

Hubing Shi.css-eqlu8i{font-size:small;padding-left:4px;}